Automated flow cytometry (FC) data analysis instruments for cell inhabitants identification and characterization are more and more getting used in tutorial, biotechnology, pharmaceutical, and scientific laboratories. The improvement of those computational strategies is designed to beat reproducibility and course of bottleneck points in handbook gating, nevertheless, the take-up of those instruments stays (anecdotally) low. Here, we carried out a complete literature survey of state-of-the-art computational instruments sometimes printed by analysis, scientific, and biomanufacturing laboratories for automated FC data analysis and recognized fashionable instruments based mostly on literature quotation counts.
Dimensionality discount strategies ranked extremely, reminiscent of generic t-distributed stochastic neighbor embedding (t-SNE) and its preliminary Matlab-based implementation for cytometry data viSNE. Software with graphical consumer interfaces additionally ranked extremely, together with PhenoGraph, SPADE1, FlowSOM, and Citrus, with unsupervised studying strategies outnumbering supervised studying strategies, and algorithm kind recognition unfold throughout Okay-Means, hierarchical, density-based, model-based, and different courses of clustering algorithms. Additionally, for example the precise use sometimes inside scientific areas alongside frequent citations, a survey issued by UK NEQAS Leucocyte Immunophenotyping to establish software utilization trends amongst scientific laboratories was accomplished.
The survey revealed 53% of laboratories haven’t but taken up automated cell inhabitants identification strategies, although amongst people who have, Infinicyt software is essentially the most often recognized. Survey respondents thought of data output high quality to be a very powerful issue when utilizing automated FC data analysis software, adopted by software velocity and degree of technical help. This overview discovered variations in software utilization between biomedical establishments, with instruments for discovery, data exploration, and visualization extra fashionable in academia, whereas automated instruments for specialised focused analysis that apply supervised studying strategies have been extra used in scientific settings.
Weighted Error Entropy-Based Information Theoretic Learning for Robust Subspace Representation
In a lot of the present illustration studying frameworks, the noise contaminating the data factors is usually assumed to be unbiased and identically distributed (i.i.d.), the place the Gaussian distribution is usually imposed. This assumption, although significantly simplifies the ensuing illustration issues, might not maintain in many sensible situations. For instance, the noise in face illustration is often attributable to native variation, random occlusion, and unconstrained illumination, which is actually structural, and therefore, doesn’t fulfill the i.i.d. property or the Gaussianity. In this text, we devise a generic noise mannequin, known as unbiased and piecewise identically distributed (i.p.i.d.) mannequin for sturdy presentation studying, the place the statistical conduct of the underlying noise is characterised utilizing a union of distributions.
We show that our proposed i.p.i.d. mannequin can higher describe the advanced noise encountered in sensible situations and accommodate the standard i.i.d. one as a particular case. Assisted by the proposed noise mannequin, we then develop a brand new information-theoretic studying framework for sturdy subspace illustration via a novel minimal weighted error entropy criterion. Thanks to the superior modeling functionality of the i.p.i.d. mannequin, our proposed studying technique achieves superior robustness towards varied varieties of noise. When making use of our scheme to the subspace clustering and picture recognition issues, we observe important efficiency beneficial properties over the present approaches.
Communication is a standard aspect in all medical consultations, affecting a variety of outcomes for medical doctors and sufferers. The rising demand for medical college students to be skilled to speak successfully has seen the emergence of interpersonal communication expertise as core graduate competencies in medical coaching around the globe. Medical colleges have adopted a variety of approaches to develop and consider these competencies. Â We included randomised managed trials (RCTs), cluster-RCTs (C-RCTs), and non-randomised managed trials (quasi-RCTs) evaluating the effectiveness of interventions delivered to college students in undergraduate or graduate-entry medical programmes.
We included research of interventions aiming to enhance medical college students’ interpersonal communication throughout medical consultations. Included interventions focused communication expertise related to empathy, relationship constructing, gathering info, and clarification and planning, in addition to particular communication duties reminiscent of listening, acceptable construction, and query model.
Integrated neighborhood case administration of childhood sickness in low- and middle-income nations
The main causes of mortality globally in kids youthful than 5 years of age (under-fives), and notably in the areas of sub-Saharan Africa (SSA) and Southern Asia, in 2018 have been infectious ailments, together with pneumonia (15%), diarrhoea (8%), malaria (5%) and new child sepsis (7%) (UNICEF 2019). Nutrition-related elements contributed to 45% of under-five deaths (UNICEF 2019). World Health Organization (WHO) and United Nations Children’s Fund (UNICEF), in collaboration with different improvement companions, have developed an strategy – now referred to as built-in neighborhood case administration (iCCM) – to deliver remedy providers for kids ‘nearer to house’.
 kappa light chain Antibody |
|
abx025345-400ul |
Abbexa |
400 ul |
EUR 523 |
|
|
kappa light chain Antibody |
|
abx025345-80l |
Abbexa |
80 µl |
EUR 286 |
|
|
 Kappa Light chain Antibody |
|
46588-100ul |
SAB |
100ul |
EUR 252 |
 Antibody) Kappa Light Chain (Kappa-IgLC) Antibody |
|
abx411144-1mg |
Abbexa |
1 mg |
EUR 551 |
|
|
Kappa Light Chain (Kappa-IgLC) Antibody |
|
abx411421-1ml |
Abbexa |
1 ml |
EUR 439 |
|
|
Kappa Light Chain (Kappa-IgLC) Antibody |
|
abx411422-05mg |
Abbexa |
0.5 mg |
EUR 662 |
|
|
Kappa Light Chain (Kappa-IgLC) Antibody |
|
abx412052-1ml |
Abbexa |
1 ml |
EUR 439 |
|
|
Kappa Light Chain (Kappa-IgLC) Antibody |
|
abx413125-1mg |
Abbexa |
1 mg |
EUR 829 |
|
|
Kappa Light Chain (Kappa-IgLC) Antibody |
|
abx415783-1mg |
Abbexa |
1 mg |
EUR 439 |
|
|
Kappa Light Chain (Kappa-IgLC) Antibody |
|
abx415786-05mg |
Abbexa |
0.5 mg |
EUR 398 |
|
|
Kappa Light Chain (Kappa-IgLC) Antibody |
|
abx415797-1mg |
Abbexa |
1 mg |
EUR 495 |
|
|
Kappa Light Chain (Kappa-IgLC) Antibody |
|
abx415799-05mg |
Abbexa |
0.5 mg |
EUR 398 |
|
|
 anti-Kappa light chain |
|
YF-PA12641 |
Abfrontier |
50 ul |
EUR 363 |
|
Description: Mouse polyclonal to Kappa light chain |
anti-Kappa light chain |
|
YF-PA12642 |
Abfrontier |
50 ug |
EUR 363 |
|
Description: Mouse polyclonal to Kappa light chain |
anti-Kappa light chain |
|
YF-PA12643 |
Abfrontier |
100 ul |
EUR 403 |
|
Description: Rabbit polyclonal to Kappa light chain |
anti-Kappa light chain |
|
YF-PA12644 |
Abfrontier |
100 ug |
EUR 403 |
|
Description: Rabbit polyclonal to Kappa light chain |
) Kappa Light Chain (HRP) |
|
10R-8330 |
Fitzgerald |
100 ug |
EUR 282 |
|
Description: Mouse monoclonal Kappa Light Chain antibody (HRP) |
 Rabbit Kappa light chain antibody |
|
70R-10679 |
Fitzgerald |
1 ml |
EUR 373 |
|
Description: Rabbit polyclonal Kappa light chain antibody |
 Ig kappa Light Chain Antibody |
|
20-abx137077 |
Abbexa |
|
|
|
|
 Antibody) kappa Light Chain (Free) Antibody |
|
abx021500-1mg |
Abbexa |
1 mg |
EUR 599 |
|
|
 Antibody) Kappa Light Chain(L1C1) Antibody |
|
BNCA0018-250 |
Biotium |
250uL |
EUR 383 |
|
Description: Primary antibody against Kappa Light Chain(L1C1), APC conjugate, Concentration: 0.1mg/mL |
 Antibody) Kappa Light Chain(KLC264) Antibody |
|
BNCA0264-250 |
Biotium |
250uL |
EUR 383 |
|
Description: Primary antibody against Kappa Light Chain(KLC264), APC conjugate, Concentration: 0.1mg/mL |
 Antibody) Kappa Light Chain(HP6053) Antibody |
|
BNCA0681-250 |
Biotium |
250uL |
EUR 383 |
|
Description: Primary antibody against Kappa Light Chain(HP6053), APC conjugate, Concentration: 0.1mg/mL |
 Antibody) Kappa Light Chain(KLC709) Antibody |
|
BNCA0709-250 |
Biotium |
250uL |
EUR 383 |
|
Description: Primary antibody against Kappa Light Chain(KLC709), APC conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
|
BNCAP0018-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Kappa Light Chain(L1C1), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
|
BNCAP0018-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Kappa Light Chain(L1C1), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC264) Antibody |
|
BNCAP0264-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Kappa Light Chain(KLC264), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC264) Antibody |
|
BNCAP0264-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Kappa Light Chain(KLC264), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(HP6053) Antibody |
|
BNCAP0681-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Kappa Light Chain(HP6053), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(HP6053) Antibody |
|
BNCAP0681-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Kappa Light Chain(HP6053), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC709) Antibody |
|
BNCAP0709-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Kappa Light Chain(KLC709), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC709) Antibody |
|
BNCAP0709-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Kappa Light Chain(KLC709), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
|
BNC810018-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Kappa Light Chain(L1C1), CF680R conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
|
BNC810018-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Kappa Light Chain(L1C1), CF680R conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC264) Antibody |
|
BNC810264-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Kappa Light Chain(KLC264), CF680R conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC264) Antibody |
|
BNC810264-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Kappa Light Chain(KLC264), CF680R conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(HP6053) Antibody |
|
BNC810681-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Kappa Light Chain(HP6053), CF680R conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(HP6053) Antibody |
|
BNC810681-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Kappa Light Chain(HP6053), CF680R conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC709) Antibody |
|
BNC810709-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Kappa Light Chain(KLC709), CF680R conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC709) Antibody |
|
BNC810709-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Kappa Light Chain(KLC709), CF680R conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
|
BNC880018-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Kappa Light Chain(L1C1), CF488A conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
|
BNC880018-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Kappa Light Chain(L1C1), CF488A conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC264) Antibody |
|
BNC880264-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Kappa Light Chain(KLC264), CF488A conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC264) Antibody |
|
BNC880264-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Kappa Light Chain(KLC264), CF488A conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(HP6053) Antibody |
|
BNC880681-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Kappa Light Chain(HP6053), CF488A conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(HP6053) Antibody |
|
BNC880681-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Kappa Light Chain(HP6053), CF488A conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC709) Antibody |
|
BNC880709-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Kappa Light Chain(KLC709), CF488A conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC709) Antibody |
|
BNC880709-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Kappa Light Chain(KLC709), CF488A conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
|
BNCB0018-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Kappa Light Chain(L1C1), Biotin conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
|
BNCB0018-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Kappa Light Chain(L1C1), Biotin conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC264) Antibody |
|
BNCB0264-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Kappa Light Chain(KLC264), Biotin conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC264) Antibody |
|
BNCB0264-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Kappa Light Chain(KLC264), Biotin conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(HP6053) Antibody |
|
BNCB0681-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Kappa Light Chain(HP6053), Biotin conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(HP6053) Antibody |
|
BNCB0681-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Kappa Light Chain(HP6053), Biotin conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC709) Antibody |
|
BNCB0709-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Kappa Light Chain(KLC709), Biotin conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC709) Antibody |
|
BNCB0709-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Kappa Light Chain(KLC709), Biotin conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
|
BNC550018-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Kappa Light Chain(L1C1), CF555 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
|
BNC550018-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Kappa Light Chain(L1C1), CF555 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC264) Antibody |
|
BNC550264-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Kappa Light Chain(KLC264), CF555 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC264) Antibody |
|
BNC550264-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Kappa Light Chain(KLC264), CF555 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(HP6053) Antibody |
|
BNC550681-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Kappa Light Chain(HP6053), CF555 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(HP6053) Antibody |
|
BNC550681-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Kappa Light Chain(HP6053), CF555 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC709) Antibody |
|
BNC550709-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Kappa Light Chain(KLC709), CF555 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC709) Antibody |
|
BNC550709-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Kappa Light Chain(KLC709), CF555 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC264) Antibody |
|
BNC430264-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Kappa Light Chain(KLC264), CF543 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC264) Antibody |
|
BNC430264-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Kappa Light Chain(KLC264), CF543 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(HP6053) Antibody |
|
BNC430681-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Kappa Light Chain(HP6053), CF543 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(HP6053) Antibody |
|
BNC430681-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Kappa Light Chain(HP6053), CF543 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC709) Antibody |
|
BNC430709-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Kappa Light Chain(KLC709), CF543 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC709) Antibody |
|
BNC430709-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Kappa Light Chain(KLC709), CF543 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
|
BNC470018-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Kappa Light Chain(L1C1), CF647 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
|
BNC470018-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Kappa Light Chain(L1C1), CF647 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC264) Antibody |
|
BNC470264-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Kappa Light Chain(KLC264), CF647 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC264) Antibody |
|
BNC470264-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Kappa Light Chain(KLC264), CF647 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(HP6053) Antibody |
|
BNC470681-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Kappa Light Chain(HP6053), CF647 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(HP6053) Antibody |
|
BNC470681-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Kappa Light Chain(HP6053), CF647 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC709) Antibody |
|
BNC470709-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Kappa Light Chain(KLC709), CF647 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC709) Antibody |
|
BNC470709-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Kappa Light Chain(KLC709), CF647 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
|
BNC940018-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Kappa Light Chain(L1C1), CF594 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
|
BNC940018-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Kappa Light Chain(L1C1), CF594 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC264) Antibody |
|
BNC940264-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Kappa Light Chain(KLC264), CF594 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC264) Antibody |
|
BNC940264-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Kappa Light Chain(KLC264), CF594 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(HP6053) Antibody |
|
BNC940681-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Kappa Light Chain(HP6053), CF594 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(HP6053) Antibody |
|
BNC940681-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Kappa Light Chain(HP6053), CF594 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC709) Antibody |
|
BNC940709-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Kappa Light Chain(KLC709), CF594 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC709) Antibody |
|
BNC940709-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Kappa Light Chain(KLC709), CF594 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
|
BNCP0018-250 |
Biotium |
250uL |
EUR 383 |
|
Description: Primary antibody against Kappa Light Chain(L1C1), PerCP conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC264) Antibody |
|
BNCP0264-250 |
Biotium |
250uL |
EUR 383 |
|
Description: Primary antibody against Kappa Light Chain(KLC264), PerCP conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(HP6053) Antibody |
|
BNCP0681-250 |
Biotium |
250uL |
EUR 383 |
|
Description: Primary antibody against Kappa Light Chain(HP6053), PerCP conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC709) Antibody |
|
BNCP0709-250 |
Biotium |
250uL |
EUR 383 |
|
Description: Primary antibody against Kappa Light Chain(KLC709), PerCP conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
|
BNCR0018-250 |
Biotium |
250uL |
EUR 383 |
|
Description: Primary antibody against Kappa Light Chain(L1C1), RPE conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
|
BNC040018-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Kappa Light Chain(L1C1), CF405S conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
|
BNC040018-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Kappa Light Chain(L1C1), CF405S conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC264) Antibody |
|
BNC040264-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Kappa Light Chain(KLC264), CF405S conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC264) Antibody |
|
BNC040264-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Kappa Light Chain(KLC264), CF405S conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(HP6053) Antibody |
|
BNC040681-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Kappa Light Chain(HP6053), CF405S conjugate, Concentration: 0.1mg/mL |
The iCCM strategy offers built-in case administration providers for 2 or extra sicknesses – together with diarrhoea, pneumonia, malaria, extreme acute malnutrition or neonatal sepsis – amongst under-fives at neighborhood degree (i.e. exterior of healthcare services) by lay well being staff the place there may be restricted entry to well being facility-based case administration providers (WHO/UNICEF 2012). Â To assess the results of the built-in neighborhood case administration (iCCM) technique on protection of acceptable remedy for childhood sickness by an acceptable supplier, high quality of care, case load or severity of sickness at well being services, mortality, antagonistic occasions and protection of careseeking for kids youthful than 5 years of age in low- and middle-income nations.
